Cover Image
市場調查報告書

無針頭藥物遞輸系統市場

The Market for Needle-Free Drug Delivery Systems

出版商 Kalorama Information 商品編碼 364519
出版日期 內容資訊 英文 160 Pages
訂單完成後即時交付
價格
Back to Top
無針頭藥物遞輸系統市場 The Market for Needle-Free Drug Delivery Systems
出版日期: 2016年07月14日 內容資訊: 英文 160 Pages
簡介

本報告提供全球無針頭藥物遞輸系統的市場調查,無針頭藥物遞輸系統定義和概要,優點及影響市場成長因素分析,無針頭注射種類與概要,其他無針頭技術類型和概要,技術開發、產品開發趨勢,各技術、用途、地區的市場規模的變化與預測,競爭環境,企業簡介等彙整資料。

摘要整理

  • 市場促進因素
  • 市場規模、成長率
  • 無針頭藥物輸送市場:各技術
  • 無針頭藥物輸送市場:各用途
  • 企業及市場分析

簡介

  • 簡介
  • 調查範圍、調查手法
  • 藥物遞輸系統
  • 作用機制
  • 針插事故
  • 安全性上的疑慮
  • 配合的變化

無針頭藥物遞輸系統

  • 技術
  • 無針頭注射技術
  • 無針頭注射技術系統的各種類型
    • 噴氣式飛機式
    • 彈簧式
    • 雷射式
  • 產品
  • 其他的無針頭技術
    • 經皮技術
      • 微針頭
      • 奈米貼片
    • 新的無針頭技術
      • 鼻腔內
      • 電子支援給藥
      • 離子引進
  • 各種用途
    • 胰島素
    • 疫苗
    • 小兒科用
    • 疼痛
    • 其他

市場趨勢、發展情形

  • 筆型注射器
  • 含生物製藥 (生技仿製藥)
  • 新的疫苗給藥的開發
    • 食用疫苗
    • 粘膜給藥
    • 鼻腔內給藥
    • 疫苗
    • 疫苗晶片
  • 給藥系統的安裝趨勢
  • 奈米技術
  • 藥物輸送的開發
    • DNA疫苗
    • 無針頭給藥的開發
    • 開發中的主要的產品
    • 超音波貼片給藥
    • 模式轉移
    • Bolus注射
    • 智慧注射器

市場規模、成長率

  • 簡介
  • 整體市場
  • 各技術市場
  • 各用途市場
  • 各地區市場
    • 歐洲
    • 亞太地區
    • 其他

競爭分析、市場分析

  • 競爭環境
  • 市場分析
    • 無針頭藥物輸送的優點
    • 無針頭藥物輸送市場成長推進因素
    • 生物製藥
    • 癌症
    • 居家醫療

總論

企業簡介

  • 3M Pharmaceuticals
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Becton Dickinson and Company
  • Bioject Medical Technologies, Inc.
  • Crossject SA
  • D'Antonio Consultants International, Inc
  • Glide Pharma Technologies Limited
  • Injex Pharma AG
  • Inovio Pharmaceuticals, Inc.
  • Medical International technologies, Inc
  • MedImmune, Inc
  • Mystic Pharmaceuticals, Inc
  • National Medical Products, Inc
  • Optinose, Inc
  • Pharmajet, Inc
  • PowderMed, Inc/Pfizer
  • Valeritas, Inc
  • Zogenix, Inc

圖表

目錄
Product Code: KLI15055265

This report ‘Needle-Free Drug Delivery’ details the types of drug delivery systems and technologies that are being used in 2016, as well as those that may become major market factors by the end of the forecast period. The report describes the industry, its relationship to various healthcare channels, and the trends for the future.

Needle-free jet injection devices can and should play a major role in solving the problems of needle-stick injuries and needle phobia in the United States. However, the needle-free jet injector industry is struggling to overcome significant obstacles in this country and abroad before these devices become widely accepted and used for administering drugs and especially vaccines. Specific trends and demographics are influencing growth of the needle-free drug delivery market. A significant influence is the growth in the elderly population. Ease of administration, frequency of administration, safety, and cost are of major importance to all consumers especially the elderly population. Needle-free drug delivery methods help to meet those needs for efficacy, safety, patient compliance, and ease of use.

As part of its extensive coverage, this report provide the following information:

  • Market Estimate and Forecast by Technology (Jet, Other)
  • Market Estimate and Forecast by Application (Insulin, Vaccine, Pediatric, Pain, Other )
  • Needle-Free Products on the Market
  • Cost per Million Injections by Injector Type
  • Seven Important Conclusions About the Market
  • Profiles of Injectable/Implantable and Needle-Free Drug Delivery Companies

Vaccine administration is a focal point of needle-free drug delivery. Providing the needed vaccines in remote areas where there are limited healthcare personnel is a goal of needle-free vaccine administration. In addition, the use of needle-free technology in the pediatric population is becoming an increasingly useful method of delivery for children, who generally require many vaccines in the early years. One of the most significant drivers of the needle-free drug delivery market is the rise in the number of biopharmaceuticals. Biopharmaceuticals have shown great promise in treating various diseases and are considered standard of care in some cases. However, most biologics are administered by injection. Needle-free administration provides a cost-effective, easy to use, safe method to administer biologics without the need for traditional injection apparatus or trained personnel.

Most needle-free jet injectors use metal springs, compressed air, or CO2 gas to power the injection. The device's nozzle is held against the patient's skin and once activated, the device injects a fine stream of the vaccine or drug at a high pressure into the skin. The most common orifice size is 0.127 mm, whereas that of a 25-gauge needle is 1 mm.. Companies are developing a new generation of sophisticated delivery systems. Targeted delivery has already advanced with new polymer-based chemotherapy implants.The geographic scope of the report is worldwide. Numbers provided in this report represent global market sizes and revenues with no regional breakout. In terms of products, the report includes data on needle-free injection delivery and implantable delivery, which includes sustained release delivery and targeted delivery systems.

As the discovery and development of new drugs create the promise of relief and improved levels of care for a variety of chronic conditions, developers are increasingly aware of the need to pair these promising new therapies, more than half of which cannot be taken orally, with delivery methods that are patient-friendly and that encourage compliance. These combination products, in which the delivery device is an integral part of the approved drug therapy, must take into account the needs of a broad range of end users, including elderly patients and those with compromised dexterity, a rapidly-growing demographic segment of the population in developed countries. For many drug developers, the answer to this challenge will increasingly be needle-free injection. While the concept behind needle-free injection is uncomplicated, it has only been recently, with the convergence of synthetic materials and computerized design software that reliable and cost-effective devices have begun to appear. New designs currently being developed will create new opportunities for needle-free injection.

Companies Covered in this report include:

  • 3M Pharmaceuticals
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Becton Dickinson and Company
  • Bioject Medical Technologies, Inc.
  • Crossject SA
  • D'Antonio Consultants International, Inc
  • Glide Pharma Technologies Limited
  • Injex Pharma AG
  • Inovio Pharmaceuticals, Inc.
  • Medical International technologies, Inc
  • MedImmune, Inc
  • Mystic Pharmaceuticals, Inc
  • National Medical Products, Inc
  • Optinose, Inc
  • Pharmajet, Inc
  • PowderMed, Inc/Pfizer
  • Valeritas, Inc
  • Zogenix, Inc.

Table of Contents

EXECUTIVE SUMMARY

  • Market Drivers
  • Market Size and Growth
  • Total Needle-free Drug Delivery Market by Technology
  • Needle-free Drug Delivery Market by Application
  • Competitor and Market Analysis

INTRODUCTION

  • Introduction
  • Scope and Methodology
  • Drug Delivery Systems
  • Phases of Drug Action
  • Needlestick Injuries
  • Safety Concerns
  • Formulation Changes

NEEDLE-FREE DRUG DELIVERY SYSTEMS

  • Technology
  • Needle-free Injection Technology
  • Types of Needle-free Injection Technology Systems
  • Jet-based Needle-free Injectors
  • Spring-based Needle-free Injectors
  • Laser-based Needle-free Injectors
  • Products
  • Other Needle-free Technology
  • Transdermal Technology
  • Microneedles
  • Nanopatches
  • Novel Needle-free Technology
  • Intranasal
  • Electronically Assisted Transport
  • Iontophoresis
  • Applications
  • Insulin Needle-free Drug Delivery
  • Vaccine Needle-free Drug Delivery
  • Pediatric Needle-free Drug Delivery
  • Pain Needle-free Drug Delivery
  • Other Needle-free Drug Delivery

TRENDS AND DEVELOPMENTS

  • Pen Injectors
  • Biologics Including Biosimilars
  • Novel Vaccine Delivery Development
  • Edible Vaccines
  • Mucosal Delivery
  • Intranasal Delivery
  • Vaccine Patches
  • Vaccine Chips
  • Delivery Systems Placement Trends
  • Nanotechnology
  • Drug Delivery Development
  • DNA Vaccines
  • Needle-Free Delivery Development
  • Selected Products in Development
  • Ultrasonic Patch Delivery
  • Paradigm Shift
  • Bolus Injectors
  • Smart Injectors

MARKET SIZE AND GROWTH

  • Introduction
  • Total Market
  • Market by Technology
  • Market by Applications
  • Market by Region
  • Europe
  • Asia Pacific
  • Rest of World

COMPETITIVE AND MARKET ANALYSIS

  • Competitive Landscape
  • Market Analysis
  • Advantages of Needle-free Drug Delivery
  • Drivers of the Needle-free Drug Delivery Market
  • Biologics
  • Cancer
  • Home Care

CONCLUSIONS

  • Conclusion 1: Product Exclusivity Can Be Extended by Novel Drug Delivery
  • Conclusion 2: Novel Drug Delivery Leads To Differentiation of Products
  • Conclusion 3: Needle-free Drug Delivery Augments Vaccine Sales, Availability and Use
  • Conclusion 4: Needle-free Devices Need To Be More Cost Effective
  • Conclusion 5: Biotech Drug Developers Will Benefit From Needle-free Delivery
  • Conclusion 6: Home Care Trend Driving Needle-free Drug Delivery Growth

COMPANY PROFILES

  • 3M Pharmaceuticals
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Becton Dickinson and Company
  • Bioject Medical Technologies, Inc.
  • Crossject SA
  • D'Antonio Consultants International, Inc
  • Glide Pharma Technologies Limited
  • Injex Pharma AG
  • Inovio Pharmaceuticals, Inc.
  • Medical International technologies, Inc
  • MedImmune, Inc
  • Mystic Pharmaceuticals, Inc
  • National Medical Products, Inc
  • Optinose, Inc
  • Pharmajet, Inc
  • PowderMed, Inc/Pfizer
  • Valeritas, Inc
  • Zogenix, Inc

TABLE OF EXHIBITS

EXECUTIVE SUMMARY

  • Figure 1-1: The Worldwide Market for Needle-free Drug Delivery Systems 2013-2020

INTRODUCTION

  • Table 2-1: Sequence of Drug Action

NEEDLE-FREE DRUG DELIVERY SYSTEMS

  • Table 3-1: Selected Needle-free injector Systems and Manufacturers

TRENDS AND DEVELOPMENTS

  • Table 4-1: Select Products in Development by Drug Delivery Companies
  • Table 4-1[continued]: Select Products in Development by Drug Delivery Companies

MARKET SIZE AND GROWTH

  • Table 5-1: The Worldwide Market for Needle-Free Drug Delivery Systems 2013-2020
  • Figure 5-1: The Worldwide Market for Needle-Free Drug Delivery 2013-2020
  • Table 5-2: The Worldwide Market for Needle-Free Drug Delivery Systems by Technology 2013-2020
  • Figure 5-2: The Worldwide Market for Needle-Free Drug Delivery Systems by Technology 2013-2020
  • Figure 5-3: The Worldwide Market for Needle-Free Drug Delivery Systems by Percent of Technology 2015
  • Table 5-3: The Worldwide Market for Needle-Free Drug Delivery Systems by Application 2013-2020
  • Figure 5-4: The Worldwide Market for Needle-Free Drug Delivery Systems by Technology 2013-2020
  • Source: Kalorama Information
  • Figure 5-5: The Worldwide Market for Needle-Free Drug Delivery Systems Distribution of Revenue by % Application 2015
  • Table 5-4: Worldwide Market for Needle-Free Drug Delivery Systems Distribution by Region,2013-2020
  • Figure 5-6: Worldwide Market for Needle-Free Drug Delivery Systems Distribution by Region,2013-2020
  • Figure 5-7: Worldwide Market for Needle-Free Drug Delivery Systems, % Distribution of Sales by Region, 2015
  • Figure 5-8: Worldwide Market for Needle-Free Drug Delivery Systems, % Distribution of Sales by European Region, 2015
  • Figure 5-9: Worldwide Market for Needle-Free Drug Delivery Systems, % Distribution of Sales by Asia Pacific Region, 2015
  • Figure 5-10: Worldwide Market for Needle-Free Drug Delivery Systems, % Distribution of Sales by Rest of World Regions, 2015

COMPETITIVE AND MARKET ANALYSIS

  • Table 6-1: Needle-Free Drug Delivery Technology Participants
  • Table 6-1 (continued): Needle-Free Drug Delivery Technology Participants
  • Figure 6-1: Cost per Million Injections by Injector Type

CONCLUSIONS

COMPANY PROFILES

Back to Top